Tissue-controlled treatment and dynamic interaction and comparison with tissue and / or treatment data

Abstract

The present disclosure relates to tissue controlled treatment and dynamic interaction and comparison with tissue and / or treatment data. An interactive treatment mapping and planning system enables a user to more quickly, thoroughly, and efficiently aggregate fibroid and / or treatment information from a user and / or one or more sets of databases, construct a fibroid map providing a visual representation of the aggregated fibroid information, generate information about a fibroid and / or treatment procedure to be treated from the aggregated information, develop a treatment plan based on the fibroid and / or treatment procedure information, provide real-time information collected from treatment devices during a treatment procedure, and allow a user to interact with treatment data.

Description

[0001] This application is a divisional application of an application with an application date of November 8, 2017, application number 201780082988.2, and invention name “Controlled treatment of tissues and dynamic interaction and comparison with tissue and / or treatment data”.

[0002] Incorporated by Reference

[0003] This application claims the benefit of priority to U.S. Provisional Patent Application No. 62 / 421,119, filed on November 11, 2016. Each of U.S. Patent Nos. 8,088,072 and 8,992,427 and U.S. Provisional Patent Application No. 62 / 421,119 is hereby incorporated by reference in its entirety to form a part of this application. Technical Field

[0004] The present disclosure generally relates to medical methods and systems for controlling the deployment of injection needles by constructing treatment maps. Embodiments of the present disclosure relate to systems and techniques for providing a user interface for dynamic interaction with fibroid data and treatment data. More specifically, embodiments of the present disclosure relate to a user interface for dynamically providing a visual representation of information generated by aggregating treatment data from one or more medical items and generating the information. background

[0005] Current medical treatment of organs and tissues within a patient's body often uses injection needles or other elongated bodies for delivery of energy, therapeutic agents, or the like. Some methods use ultrasound imaging to observe and identify treatment targets, and predict and track the position of injection needles relative to the treatment targets.

[0006] Treatments for uterine fibroids have recently been proposed that rely on transvaginal or laparoscopic positioning of a treatment device in the patient's uterus. A radiofrequency or other energy or treatment delivery injection needle is deployed from the device into the fibroid, and energy and / or therapeutic substances are delivered to remove or treat the fibroid. To facilitate positioning of the fibroid and placement of the injection needle within the fibroid, the device includes an ultrasound imaging array having an adjustable field of view in a generally forward or lateral direction relative to an axial shaft carrying the injection needle. The injection needle is advanced from the shaft and across the field of view so that the injection needle can be visualized and guided into the tissue and target fibroid.

[0007] Overview

[0008] The systems, methods, and devices described herein each have several aspects, no single one of which is solely responsible for its desirable attributes.Without limiting the scope of the present disclosure, several non-limiting features will now be briefly described.

[0009] Embodiments of the present disclosure relate to interactive treatment mapping and planning systems and techniques for inputting and / or receiving fibroid data, generating information from fibroids and / or treatment data, and displaying visual representations of treatment data to enable a user to efficiently obtain information in an interactive user interface. The system may include techniques for providing real-time updates detailing ongoing treatment data. Disclosed herein is a system that advantageously provides highly effective, intuitive, and rapid dynamic interaction with fibroid data and treatment data to enable a user to generate information about a treatment process. The system may include a dynamically updated interactive user interface to provide a rapid comparison of multiple fibroids to be treated. In addition, for example, in some embodiments, treatment information may be automatically categorized by the system according to attributes associated with the treatment process and the user's rules and / or preferences.

[0010] Systems and methods for providing a treatment mapping and planning system are disclosed. The system provides fibroid locations on a user interface. The user interface may include a map of the fibroids to be treated and / or treatment process information and activities at the level of individual fibroids. A user may select a fibroid to be treated from the user interface, and the system may prompt the user to provide information about the fibroid to the system. Thus, a user may use the system described herein to more quickly, more thoroughly, and more efficiently interact with multiple fibroid information and develop an effective treatment plan based on the various fibroids to be treated. The features and advantages mentioned above and other features and advantages will be discussed in further detail below.

[0011] In various embodiments, the system creates a representation of the fibroid to be treated including, for example, a description of the fibroid, fibroid location, fibroid type (e.g., intramural, submucosal, subserosal, pedunculated submucosal, pedunculated subserosal), estimated fibroid size, and other fibroid information.

[0012] In various embodiments, systems and methods for aggregating fibroid and / or treatment data points and generating information about the course of treatment are disclosed. For example, the fibroid and / or treatment data points may include at least one of fibroid location, fibroid size, fibroid treatment sequence, or other fibroid information.

[0013] In various embodiments, systems and methods are disclosed for aggregating fibroid and / or treatment data points from various data sources. For example, the various data sources may include at least one of input from a user, a user data source, or a third-party data source.

[0014] In various embodiments, the system provides color-coded icons including treatment order and other information. Other information may include estimated fibroid size, fibroid treatment status, and other fibroid information. Alarms may alert the user to situations where a mapped fibroid is not being treated.

[0015] In various embodiments, systems and methods are disclosed for classifying fibroids to be treated based on aggregated fibroid information. Classification can be based on fibroid size, treatment sequence, fibroid location, fibroid pre-treatment state, and other fibroid information. The system can automatically identify the mapped fibroids as fibroids of particular interest to the user based on the classification, and provide the user with a visual representation indicating the state of the fibroid. The user can then select the fibroid and interact with the fibroid.

[0016] In various embodiments, data from a therapeutic device can be acquired during a therapeutic process. The therapeutic data can be automatically and dynamically interactively processed in response to user and therapeutic device inputs, and the processed data is efficiently and compactly presented to the user by the system. Thus, in some embodiments, the user interface described herein is more efficient than previous recording methods in which the therapeutic data is not dynamically updated and compactly and efficiently presented to the user in response to use of the therapeutic device.

[0017] The system can be configured and / or designed to generate user interface data that can be used to reproduce the various interactive user interfaces described. The user interface data can be used by the system and / or another computer system, device, and / or software program (e.g., a browser program) to reproduce the interactive user interface. The interactive user interface can be displayed, for example, on an electronic display (including, for example, a touch-enabled display).

[0018] In various embodiments, systems and methods for generating a user interface including a fibroid map are disclosed. The fibroid map can include a visual representation of information related to a fibroid. For example, the visual representation can include a fibroid icon.

[0019] In various embodiments, systems and methods are disclosed for identifying a fibroid using an imaging modality and generating a user interface configured to provide knowledge related to the identified fibroid.

[0020] In various embodiments, systems and methods for acquiring data from an imaging device are disclosed. For example, the data may include at least one of the imaging device position, imaging device orientation, insertion depth, insertion angle, fibroid location, fibroid size, or other imaging device information.

[0021] In various embodiments, systems and methods are disclosed for gathering information about a therapeutic device via sensors. For example, the information may include at least one of a location and an orientation of the therapeutic device.

[0022] In various embodiments, systems and methods for communicating information from a sensor to a mapping system are disclosed.For example, the sensor may communicate information related to at least one of a position and an orientation of a therapeutic device.

[0023] In various embodiments, systems and methods are disclosed for gathering information related to an imaging device through a tracking system. For example, the information may include at least one of the position, orientation, and motion of the imaging device.

[0024] The design of a computer user interface that is usable by humans and easy to learn is a nontrivial problem for software developers. The present disclosure describes various embodiments of interactive and dynamic user interfaces as a result of significant developments. This extraordinary development results in the user interface described herein, which can provide significant cognitive and ergonomic efficiencies and advantages over previous methods. The interactive and dynamic user interface includes improved human-computer interaction, which can provide users with reduced mental workload, improved decision-making, reduced work stress, reduced process time, increased process accuracy, increased process documentation, and / or the like. For example, user interaction with an interactive user interface (including interaction with fibroid and / or treatment data together with other interactions described herein) can provide optimized interaction compared to previous methods.

[0025] Various embodiments of the present disclosure provide improvements in various technical and technological fields. For example, existing treatment mapping and planning application technologies are limited in various ways, and various embodiments of the present disclosure provide significant improvements to such technologies. For example, existing treatment mapping and planning application technologies are limited because the provided treatment data may not be effectively or not presented at all, and the interaction between the treatment device and the system is limited or not provided at all. Various embodiments of the present disclosure are inevitably linked to computer technology. In particular, various embodiments rely on the aggregation of fibroids and / or treatment data, the generation of information about the treatment process, the display of such data in an interactive graphical user interface displayed on an electronic display, and the like. In some embodiments, the treatment data may include information about the treatment device, treatment parameters, the date and / or time of treatment, and other information. Such features are inevitably linked to computer technology and are implemented by computer technology, and would not exist if it were not for computer technology. For example, the interaction with the displayed data described below with respect to various embodiments cannot be reasonably performed by humans alone without the computer technology on which they are implemented. Furthermore, implementing various embodiments of the present disclosure through computer technology achieves many of the advantages described herein, including more efficient interaction with and display of various types of electronic data.

[0026] Some embodiments of the disclosure are described below with respect to the appended claims, which may serve as an additional summary of the disclosure.

[0027] In various embodiments, a system and / or computer system is disclosed that includes a computer-readable storage medium and one or more processors, the computer-readable storage medium having program instructions embodied therewith, and the one or more processors are configured to execute the program instructions to cause the one or more processors to perform operations including one or more aspects of the above-mentioned and / or following embodiments (including one or more aspects of the appended claims).

[0028] In various embodiments, a computer-implemented method is disclosed in which one or more aspects of the above and / or below described embodiments (including one or more aspects of the appended claims) are implemented and / or performed by one or more processors executing program instructions.

[0029] In various embodiments, a computer program product is disclosed that includes a computer-readable storage medium having program instructions embodied therewith, the program instructions being executable by one or more processors to cause the one or more processors to perform operations including one or more aspects of the above-described and / or following embodiments (including one or more aspects of the appended claims). BRIEF DESCRIPTION OF THE DRAWINGS

[0030] The following drawings and associated descriptions are provided to illustrate embodiments of the present disclosure and do not limit the scope of the claims. The aspects of the present disclosure and many of the attendant advantages will become more readily appreciated when understood in conjunction with the accompanying drawings, as these aspects and advantages become better understood by reference to the following detailed description, wherein:

[0031] Figure 1 is a flow chart of an illustrative operation of an example interactive treatment mapping and planning system.

[0032] Figure 2 An example graphical user interface of an interactive treatment mapping and planning system is shown.

[0033] Figure 3 An example graphical user interface is shown with the constructed fibroid map located next to a user interface of an interactive treatment mapping and planning system, where icons of various types of fibroids are displayed along with a representation of the uterus.

[0034] Figure 4 An example graphical user interface of an interactive treatment mapping and planning system is shown, wherein a fibroid map indicates that a fibroid has been treated.

[0035] Figure 5 An example graphical user interface of an interactive treatment mapping and planning system is shown, wherein a fibroid map indicates that all fibroids have been treated.

[0036] Figure 6 An example of a treatment report that may be generated by the interactive treatment mapping and planning system is shown, in which a single fibroid has been treated.

[0037] Figure 7 Another example of a treatment report that may be generated by the interactive treatment mapping and planning system is shown, in which several fibroids have been treated.

[0038] Figure 8 is a block diagram illustrating an example interactive treatment mapping and planning system.

[0039] Fig. 9 is a flow chart of an illustrative operation of an example interactive treatment mapping and planning system.

[0040] Fig. 10A is an example diagnostic device configured as an interactive treatment mapping and planning system for identifying fibroids in the uterus.

[0041] Fig. 10B An example of a fibroid map interface of an interactive treatment mapping and planning system is shown, where icons of various types of fibroids may be displayed along with a representation of the uterus.

[0042] Fig. 10C is an example diagnostic device configured as an interactive treatment mapping and planning system for identifying fibroids in the uterus.

[0043] Fig. 10D An example of a fibroid map interface of an interactive treatment mapping and planning system is shown, where icons of various types of fibroids may be displayed along with a representation of the uterus. Detailed Description

[0044] The present disclosure provides improved systems and methods for treating tissues (e.g., uterine fibroids). Systems and methods allow treating physicians to interactively and efficiently access information to assist in developing treatment maps and plans. Access to such information can facilitate the planning and treatment of target tissues and increase the likelihood that appropriate treatment of target anatomy will occur. Systems and methods provide user interfaces for real-time dynamic interaction and feedback on treatment data. If necessary, such information can allow physicians to change or reassess treatment plans before and / or during the treatment process. Systems and methods provide user interfaces that can dynamically generate visual representations of information by aggregating treatment data from one or more treatment devices and generating useful information.

[0045] Feedback or other information is preferably provided visually on the treatment mapping and planning application. The treatment mapping and planning application may typically have a graphical user interface including a real-time image overlaid by or with various objects and fibroid data. In some embodiments, the image may include an ultrasound or other imaging screen. The application may also be able to gather real-time information collected from one or more treatment devices and display the information in an interactive manner to provide information to the user. For example, real-time information may include feedback information in response to manipulating the probe and / or activating the injection needle. The system automatically gathers information, reducing the need to enter data or commands into the system controller or display, and can reduce the risk of complete loss of data.

[0046] The application may generate a treatment report including information about the fibroid, treatment device, treatment parameters, date and / or time of treatment, and other treatment information.

[0047] Although certain preferred embodiments and examples are disclosed below, the inventive subject matter extends beyond the particularly disclosed embodiments to other alternative embodiments and / or uses and modifications and equivalents thereof. Therefore, the scope of the claims attached hereto is not limited by any specific embodiment described below. The structures, systems and / or devices described herein may be embodied as integrated components or separate components. For the purpose of comparing various embodiments, certain aspects and advantages of these embodiments are described. Not all such aspects or advantages are necessarily achieved by any particular embodiment. Therefore, for example, various embodiments may be implemented in a manner that realizes or optimizes an advantage or a group of advantages as taught herein, without necessarily realizing other aspects or advantages as may be taught or suggested herein.

[0048] Unless otherwise noted, the systems and methods described herein may be used with any of the embodiments described and / or contemplated in U.S. Patent Nos. 8,088,072 and 8,992,427. It should be understood that any of the embodiments described and / or contemplated in U.S. Patent Nos. 8,088,072 and 8,992,427 may be modified for use with the systems and methods described herein.

[0049] I. Overview

[0050] The interactive treatment mapping and planning system enables a user to more quickly, thoroughly, and efficiently aggregate fibroid and / or treatment information from users and / or data sources, construct a fibroid map that provides a visual representation of the aggregated fibroid information, generate information about the fibroid and / or treatment procedure to be treated from the aggregated information, develop a treatment plan based on the fibroid and / or treatment procedure information, provide real-time information collected from treatment equipment during the treatment procedure, and allow the user to interact with the treatment data. This and other functions and advantages are provided through an interactive graphical user interface, including an interactive mapping interface that is inevitably linked to computer technology.

[0051] As mentioned above, the system enables a user to efficiently input and / or edit fibroid data, construct a fibroid map, develop a treatment plan, collect information about the course of treatment, and generate a treatment report. The interactive treatment mapping and planning system may include an interactive user interface, wherein fibroid and / or treatment data may be displayed on the user interface.

[0052] Fibroid data may refer to any type of data and / or information associated with a fibroid to be mapped. Fibroid data may also be referred to herein as fibroid data items. Fibroid data items typically include at least a location associated with a fibroid. For example, in some embodiments, the location may be specified by a user at a specified location selected on a projection image located on or next to a user interface. In some instances, fibroid data may include other information. For example, fibroid data may include a description of the fibroid, fibroid location, fibroid type (e.g., intramural, submucosal, subserous, pedunculated submucosal, pedunculated subserous), estimated fibroid size, fibroid pre-treatment status, number of fibroids, fibroid treatment sequence, and / or other fibroid information. Any combination of different types of fibroid data items may be used in the system at the same time. Fibroid data items may come from various sources and may be associated with various types of fibroids. Fibroid data may be obtained from a user, a single database, and / or multiple databases. Single and / or multiple databases from which fibroid data may be obtained may be operated, maintained, and / or owned by various entities. For example, fibroid data may be obtained from a patient database and / or a hospital record management database.

[0053] Treatment data may refer to any type of data and / or information related to the treatment process. Treatment data may also be referred to as treatment data items herein. Treatment data items typically include at least information about treatment equipment, treatment parameters, date and / or time of treatment, and / or other treatment information. In some instances, treatment data may include other information. For example, treatment data may include fibroid treatment sequence, treatment time, ultrasound device information (e.g., ultrasound device serial number), ultrasound transducer angle, ultrasound transducer position, ablation device information (e.g., ablation device serial number), injection needle deployment depth, electrode deployment length, ablation data, ablation treatment volume, ablation treatment area, ablation time, ablation temperature, electrode and / or tissue impedance, radio frequency power, radio frequency temperature, time-temperature curve, time-radio frequency power curve and / or other treatment information. Any combination of different types of treatment data items may be used in the system at the same time. Treatment data items may come from various sources. Throughout the treatment process, treatment data may be obtained from a user and / or treatment equipment. For example, treatment data may be obtained from various treatment equipment (e.g., ultrasound equipment and / or ablation equipment).

[0054] Figure 1 A flowchart depicting an illustrative operation of an interactive treatment mapping and planning system is shown. In various embodiments, fewer blocks or additional blocks may be included in the process, or the process may be performed in a manner similar to that described in the example of FIG. Figure 1 The various blocks are executed in a different order than shown. In an embodiment, Figure 1 One or more blocks in can be Figure 8The illustrated interactive treatment mapping and planning system 800 performs or is implemented in the interactive treatment mapping and planning system 800 .

[0055] At block 102, the system may optionally receive various fibroid data from user input and / or one or more databases and / or data sources (e.g., including from databases maintained by the user or a third party entity). As an example of a system that receives various fibroid data, the system may access fibroid data from one or more data sources. The data may include computer readable output from a diagnostic test (e.g., transcervical uterine ultrasound, laparoscopic ultrasound, or intrauterine ultrasound). The diagnostic test may be performed on a uterine surface. Figure 1 Before or with the operation shown Figure 1 The operations shown are performed simultaneously.

[0056] The data may then optionally be processed by a server at block 104. For example, the fibroid data may be organized by location, type, and / or by any other useful index to enable rapid searching of the fibroid data.

[0057] At block 106, a user interface (and / or user interface data) is generated that displays (and / or can be used to generate and display) a mapping interface, as described in further detail below. For example, as described in further detail below, a mapping interface detailing the constructed fibroid map can be displayed on a user interface. The mapping interface can be constructed completely automatically based on the received data, completely by the user, or a combination thereof. For example, the mapping interface can be automatically populated based on the received data and then manipulated by the user. In various embodiments, the system creates a visual representation of the fibroid data and / or treatment data on the generated user interface, including, for example, a description of the fibroid, the location of the fibroid, the type of fibroid (e.g., intramural, submucosal, subserosal, pedunculated submucosal, pedunculated subserosal), the estimated fibroid size, the pre-treatment state of the fibroid, the number of fibroids, the order of fibroid treatment, and other fibroid information. In various embodiments, the system can create a populated fibroid map after a preliminary exploration process, as described below with respect to Fig. 9 described.

[0058] At block 108, the user may interact with the user interface of the system in any manner described below. For example, the user may import additional data, interact with the mapping interface, provide various search query criteria, etc. At block 110, fibroid data may be accessed by the system based on the provided user action. In various embodiments, the treatment system may access one or more internal and / or external databases in response to the user action. One or more of the accessed internal and / or external databases may or may not include the fibroid data described above.

[0059] At block 112, the system may develop a treatment plan based on the constructed fibroid map. The treatment plan may be developed manually by the user. In some embodiments, the system may automatically develop a treatment plan based on the fibroid data, as described in further detail below. The user may modify the automatically created treatment plan (e.g., change the order in which fibroids are treated, choose to skip treatment of some fibroids, etc.). Some changes may be prohibited or generate error or warning messages. The system may suggest changes to the manually created treatment plan.

[0060] At block 114, the user interface can be updated in response to the user's actions. The system can update the user interface after the treatment process begins. The updated interface can include data obtained from the treatment device. For example, the user interface can display information about the treatment device, treatment parameters, the date and / or time of treatment, and other treatment information described in more detail herein. Treatment can be blocked by the system unless the treatment is linked to a specific fibroid. Fibroid information can be displayed in a list and / or in the mapping interface, and / or animation can be provided along with other interface updates described below. As shown by arrow 116, the operation can return to block 106 so that the user can update and / or enter a new action. After returning, one or more of blocks 106, 108, 110 and / or 112 can be skipped.

[0061] At block 118, the system determines whether the treatment process has been terminated. The system may determine whether sufficient treatment has been performed before terminating the treatment process. In some embodiments, if the system determines that additional treatment is needed, the system may not terminate the treatment process. As shown by arrow 120, if the treatment process has not been terminated, the operation may continue to update the user interface when the user interacts with the system in any of the various ways described herein. If the treatment process has been terminated, the process continues to block 122.

[0062] In various embodiments, fibroid and / or treatment data may be received and processed by the system at any time and / or continuously. In embodiments, treatment data may be updated even if a user is viewing the data on a user interface. For example, a user may use the system to analyze substantially real-time treatment data.

[0063] At block 122, the system can generate a report after the treatment process is terminated. The report can detail the treatment information obtained during the treatment process. For example, the report can include information about the fibroid, treatment equipment, treatment parameters, date and / or time of treatment, etc. The report is described in further detail below.

[0064] The system may generate an alert to the user. The alert may include, for example, an electronic notification of changes and / or updates associated with the user's actions. For example, when treatment data is updated in the system, the system may determine a new or different fibroid classification, or may determine that a user interface is updated or will be updated as a result of the update. Therefore, in order to allow the user to be aware of these changes in a timely manner, the alert and / or notification may be automatically transmitted to, for example, a device operated by the user. The alert and / or notification may be transmitted at the time when the alert and / or notification is generated or at a certain time after the generation of the alert and / or notification. When received by the device, the alert and / or notification may cause the device to display the alert and / or notification by activating an application on the device. In some embodiments, the device may include a browser, a mobile application, etc. For example, the receipt of the alert and / or notification may automatically activate an application on the device, such as a messaging application, a stand-alone application, or a browser, and display the information included in the alert and / or notification. In some embodiments, the stand-alone application may include an interactive treatment mapping and planning system application. Alerts may include notification that one or more fibroids are not being treated, that treatment parameters may not be consistent with estimated fibroid size, that there is a problem with the treatment device or a portion thereof (e.g., one or more thermocouples are providing inconsistent data), and the like.

[0065] Embodiments of the present invention will now be described with reference to the accompanying drawings, wherein like numerals refer to like elements throughout. The terminology used in the description provided herein is not intended to be interpreted in any limited or restrictive manner, merely as it is utilized in conjunction with the detailed description of certain specific embodiments of the present disclosure. Embodiments of the present disclosure may include several novel features, none of which is solely responsible for its desirable attributes or essential to practicing the embodiments of the present disclosure described herein.

[0066] II. Example User Interface and Building a Fibroid Map

[0067] Figure 2-5 An example of a graphical user interface 200 for an interactive treatment mapping and planning system is shown. The user interface 200 may include an imaging field 202 that displays a real-time image obtained from an ultrasound device or another imaging device. The user interface 200 may also include a fibroid map interface 204 to assist the user before and / or during a treatment procedure. The fibroid map interface 204 may allow the user to obtain a comprehensive view of the mapped fibroids and develop a treatment plan before beginning a treatment procedure. The fibroid map interface 204 may be created using diagnostic images from an ultrasound device. The fibroid map interface 204 may be based on diagnostic data derived from other systems. The fibroid map interface 204 may display one or more images or illustrations of the uterus. For example, in some embodiments, the fibroid map interface 204 may display several views of the uterus. Figure 2-5 As shown, the several views may include an anterior uterine view 206 and / or a lateral uterine view 208. One or more uterine views 206, 208 may be annotated with a direction indicator (e.g., left, right, lateral, middle, anterior, posterior, dorsal, ventral, inferior, superior) to allow a user interacting with the one or more uterine views 206, 208 to determine the direction. For example, the anterior uterine view 206 may indicate the right side and / or the left side. For another example, the lateral uterine view 208 may indicate the front side and / or the back side.

[0068] The fibroid map interface 204 may be located at various portions of the user interface 200. In some embodiments, the fibroid map interface 204 may overlay a portion of the user interface 200 (e.g., Figure 2-5 202). The user can interact with the fibroid map interface 204 to adjust the size of the fibroid map interface 204 and / or move the fibroid map interface 204 around any portion of the user interface 200, such as to change the obstruction of the field of view of the imaging field 202. In some embodiments, the user interface 200 can include a separate viewing window or split screen window that provides the fibroid map interface. In this case, the fibroid map interface 204 that obstructs the imaging field 202 will not be displayed.

[0069] The user interface 200 and / or the fibroid map interface 204 may also include several additional icons or buttons to increase the functionality of the system. In some embodiments, the user interface 200 may include a fibroid map interface view button 210. When the user engages the view button 210, the system may display the fibroid map interface 204. When the user engages the view button 210 again, the system may then remove the fibroid map interface 204 from view. In some embodiments, the fibroid map interface 204 may be removed from view when the user engages the fibroid map interface close button 212. In some embodiments, the fibroid map interface may be removed from view or reduced in size upon user action (e.g., operation of a treatment device).

[0070] The user interface 200 and / or the fibroid map interface 204 may also include a treatment report button 214, which, when pressed by the user, causes the system to generate a treatment report 600, 700, which will be discussed in further detail below.

[0071] In various embodiments, the functionality of the interactive treatment mapping and planning system (as described below with respect to the various figures) may be implemented in one or more software computer modules stored in memory and executed by one or more hardware processors, as described below with reference to Figure 8The example interactive treatment mapping and planning system 800 in FIG. 800 can be designed to operate with a treatment device, display a user interface 200, and / or generate treatment reports 600, 700.

[0072] In various embodiments, Figure 2-5 The user interface 200 of the interactive treatment mapping and planning system can be displayed on an electronic display viewable by a user of the interactive treatment mapping and planning system. The user of the interactive treatment mapping and planning system can interact with the user interface 200 by, for example, touching the display when the display is touch enabled, clicking on various elements of the user interface 200 using a mouse pointer, and / or entering data using a keyboard. Figure 2-5 The user interface 200 interacts with.

[0073] A user of the system may interact with the user interface 200 by scrolling or panning up, down, and / or side to side, zooming in or out, selecting data items, drawing shapes, performing search queries, and / or the like. Various user actions may reveal more or less details of the user interface 200 and / or the fibroid map interface 204 and / or more or fewer data items.

[0074] Figure 3 Shown according to Figure 1 106 of the interactive treatment mapping and planning system, wherein various types of fibroid data items are displayed. In some embodiments, the system utilizes a graphical fibroid map interface 204 to display a visual representation that provides the user with insightful information about the mapped fibroids. In some embodiments, the system displays a visual representation that provides the user with information related to the fibroid data along with other information without the user having to return to one or more fibroid data sources.

[0075] Prior to the start of the treatment process, the system receives fibroid data. In some embodiments, a user can interact with the user interface 200 and / or the fibroid map interface 204 to manually populate the fibroid map interface 204 with fibroid information. A user can view fibroid information based on previously collected diagnostic results. After locating one or more fibroids through a preliminary ultrasound or other imaging device exploration process, the user can enter the fibroid information into the user interface 200 and / or the fibroid map interface 204. The system can automatically populate the fibroid map interface 200 with the fibroid information. During the preliminary exploration process, the system can generate fibroid information by aggregating information from the user and / or one or more separate data sources, which is referred to below. Fig. 9Further detailed discussion. In some embodiments, as described above, the system can automatically obtain fibroid data from a single and / or multiple databases, from which the fibroid data can be obtained, which databases can be operated, maintained and / or owned by various entities. One or more databases may include a patient database and / or a hospital record management database. After the fibroid information is entered manually by a user or automatically by the system, the system can track and record the fibroid information.

[0076] Various data items, including fibroid data items, may be represented on the fibroid map interface 204 using icons and / or symbols. Figure 2-5 Several examples of fibroid icons 216 that may represent fibroid data on the uterine views 206, 208 are shown. A user may select fibroid data and / or otherwise interact with the fibroid data for each fibroid icon 216 displayed on the fibroid map interface 204. In various embodiments, the system may display the fibroid icons 216 as representations of the fibroid data, including, for example, a description of the fibroid, fibroid location, estimated fibroid size, fibroid pre-treatment status, number of fibroids, fibroid treatment sequence, and other fibroid information.

[0077] The user can manually populate the fibroid map interface 204 by interacting with the fibroid icon 216 within the fibroid icon selection tray 218. As discussed above, the user can interact with the system by various means. For example, the user can click on the fibroid icon 216 and drag the fibroid icon 216 to a desired location. For another example, the user can click on the fibroid icon 216, and then click on the desired location to place the fibroid icon 216 at that location. The user can click on the desired location to place the fibroid icon 216, and then click on the fibroid icon 216 to place the fibroid icon 216 at that location. When the user places the fibroid icon 216 in one uterine view 206, 208, the system can automatically populate the other uterine view 206, 208 with the fibroid icon 216 at the same location on the uterus. The user can change the location of the fibroid icon 216 by interacting with the fibroid icon 216. In some embodiments, when the user moves a fibroid icon 216 up or down in a single uterine view 206, 208, the system may automatically move the corresponding fibroid icon 216 in the other uterine view 206, 208. When the user moves a fibroid icon 216 left or right in a single uterine view 206, 208, the system may not change the position of the corresponding fibroid icon 216 in the other uterine view 206, 208. This allows the fibroid icon 216 to remain at a representative horizontal position of the fibroid icon 216 on the fibroid map interface 204.

[0078] In various embodiments, the system displays each fibroid icon 216 on the fibroid map interface 204 with a specific visual representation. Each fibroid icon 216 can represent the type of fibroid associated with the fibroid data item. The fibroid icon 216 can be selected from a fibroid icon selection tray 218 based on the attributes of the fibroid, as discussed in further detail below. The visual representation may be able to quickly and efficiently provide valuable fibroid information to the user. The system can assign a specific representation to the fibroid data item based on the fibroid information generated from the aggregated information. The visual representation of the fibroid icon 216 can be animated to display, among other things, recent activity, such as changes in fibroid treatment status, fibroid treatment order, or other fibroid information.

[0079] The fibroid icon 216 may include different sizes to represent changes in the estimated fibroid size. Figure 3 As shown, the fibroid icon 216 can be selected from a large fibroid icon 216A, a medium fibroid icon 216B, and a small fibroid icon 216C displayed in a fibroid icon selection tray 218. The fibroid selection tray 218 can include a conical or frusto-conical scale in which the user can click along the vertical axis to select from a simulated classification of sizes. The fibroid selection tray 218 can prompt the user to enter a numerical fibroid estimate size and then base the fibroid icon 216 thereon. The fibroid icon 216 can provide the user with the ability to interact with the fibroid icon 216 to change the properties of the fibroid icon 216. For example, a user can click and drag on a portion of the fibroid icon 216 to increase or decrease the size of the fibroid icon 216. This provides the user with the option of changing the size of the fibroid icon 216 to any desired representative fibroid size. The fibroid icon 216 can be circular / spherical (e.g., as Figure 2-5 In such embodiments, the fibroid icon 216 may be stretched, narrowed, rotated, etc. The user may change the properties of the fibroid icon 216 before and / or after the fibroid icon 216 is placed on the fibroid map interface 204. The fibroid icon 216 may be a graphical representation showing relative fibroid size and fibroid location in the uterus.

[0080] like Figure 3 As shown, the fibroid map interface 204 can display various visual representations that provide the user with insightful information about the mapped fibroids. For example, the fibroid icon 217 indicates the presence of a large (216A sized) fibroid located on the posterior side of the right wall of the uterine cavity. The fibroid icon 217 is yellow, which indicates that the fibroid is not being treated. Figure 4 and Figure 5As shown, a white fibroid icon indicates that the fibroid has been treated. Other colors and schemes for indicating treatment are also possible. For example, a grayscale color scheme can be used to distinguish between fibroid icons 216 indicating untreated and treated fibroids. As described below, the fibroid treatment status can be changed during and / or after the treatment process. Figure 3 Three other fibroids of various estimated sizes and locations are also shown.

[0081] In some embodiments, a user can select (e.g., by clicking, hovering over, etc.) one or more displayed fibroid icons 216 via the fibroid map interface 204 to cause the system to display additional fibroid details. Additional information can be displayed in the fibroid map interface 204 or in a separate portion of the user interface 200. These capabilities can improve user efficiency by authorizing users to access fibroid data through the user interface 200.

[0082] In some embodiments, the user can further interact with the fibroid icon 216 to change various other fibroid properties, such as the fibroid treatment order (e.g., changing the number if the number indicates a treatment order), fibroid treatment status (e.g., marking as treated), fibroid location (e.g., as described above), and / or other fibroid information.

[0083] In some embodiments, the user interface 200 and / or the fibroid map interface 204 may include a legend.

[0084] Embodiments of the interactive treatment mapping and planning system relate to systems that facilitate the treatment of fibroids. Those skilled in the art will appreciate that the fibroids described herein may include any fibroids and are not limited to a particular location or type of fibroid. It should be understood that the term "fibroid" should be interpreted broadly and include any abnormal tissue growth or any other surface or other condition or defect within a patient's uterus or other circumstances that benefit from ablative treatment. For example, the term "fibroid" may be used herein to describe ectopic glandular tissue or myometrium (endometriosis or endometrial tissue ectopic) found in the muscle wall of the uterus.

[0085] III. Develop a treatment plan

[0086] exist Figure 1 At block 112 of the embodiment, a user may develop a treatment plan based on the fibroid map interface 204 after the construction of the fibroid map interface 204. In an alternative embodiment, the system may automatically develop a treatment plan based on the constructed fibroid map interface 204 and the gathered fibroid information. The treatment plan may include showing the fibroid icon 216 on the fibroid map interface 204 to include a number indicating the order of fibroid treatment, such as Figure 3-5As shown. The user and / or the system can change the fibroid treatment order for the fibroid icon 216. The automatic fibroid treatment order can be based on one or more parameters, including, for example, fibroid size (e.g., from largest to smallest, from smallest to largest), fibroid location (e.g., from uppermost to lowermost, from lowermost to uppermost, from most submucosal to most subserosal), likelihood of outgassing, ease of access, combinations thereof, and the like. As a non-limiting example, a parameter can be given a weighted score to recommend treatment of a superior small submucosal fibroid before treatment of a lower-middle intramural fibroid.

[0087] The treatment plan may target the fibroids farthest from the serosa before the fibroids closest to the serosa. The treatment plan may target pedunculated submucosal fibroids, submucosal fibroids, intramural fibroids, subserosal fibroids, and finally pedunculated subserosal fibroids in the order listed.

[0088] In some embodiments, the fibroid treatment sequence can be designed to avoid blurring the imaging field 202. Blurring may be produced by a process known as degassing, which occurs when vapor produced during ablation of the fibroid changes the quality of the image produced by the ultrasound or other imaging device. Therefore, a treatment plan can be formulated to avoid degassing. Several factors (e.g., the mapped fibroid location, fibroid size, other fibroid information, treatment parameters (e.g., temperature, time, temperature ramp, etc.), etc.) may affect the extent to which degassing occurs during the treatment process. In some embodiments, a treatment plan can be formulated that treats fibroids located farther within the uterine cavity before treating fibroids closer to the cervix. Alternatively, fibroids located closer to the cervix can be treated before fibroids located farther within the uterine cavity. A treatment plan can be formulated to treat fibroids located closer to the surface of the endometrium, as opposed to fibroids located deeper within the uterine wall. Fibroid size may be a factor in determining the order in which fibroids are treated. Embodiments of the interactive treatment planning and mapping system may utilize a combinatorial optimization algorithm to determine an improved or optimal fibroid treatment sequence subject to treatment constraints and / or treatment parameters (e.g., temperature, time, temperature ramping, reducing or avoiding degassing, fibroid size, fibroid location, number of fibroids, etc.).

[0089] In some embodiments, the imaging field 202, the fibroid map interface 204, or a combination of both may be used to determine the placement and / or position of the therapeutic device during the treatment process. The interactive treatment planning and mapping system may determine the placement and / or position of the therapeutic device based on the fibroid data and the treatment data. Several factors (e.g., the mapped fibroid location, fibroid size, other fibroid information, treatment parameters (e.g., temperature, time, temperature ramp, etc.), and other information) may affect the placement of the therapeutic device. The user interface may also include a therapeutic device placement and / or position indication on the imaging field 202, the fibroid map interface 204, or a combination of both. The indication may instruct the user to place the therapeutic device in a specific positioning and / or position during the treatment process. An embodiment of the interactive treatment planning and mapping system may utilize a combined optimization algorithm to determine an improved or optimal therapeutic device position and / or placement subject to treatment constraints and / or treatment parameters (e.g., temperature, time, temperature ramp, reduction or avoidance of degassing, fibroid size, fibroid location, number of fibroids, etc.).

[0090] In some instances, the treatment device may be configured to sense its position and / or orientation in space. The treatment device may transmit its position and / or orientation information to an interactive treatment planning and mapping system. The system may incorporate the position and / or orientation information into the imaging field 202, the fibroid map interface 204, or a combination of the two for display to the user. The treatment device may include one or more sensors to measure the position and / or orientation of the treatment device in three-dimensional space. The sensor may transmit the position and / or orientation information to the interactive treatment planning and mapping system so that the position and / or orientation information of the treatment device may be displayed in the imaging field 202 and / or the fibroid map interface 204. In some instances, the treatment device is in the form of an ablation tool including an injection needle, but the treatment device may include other ablation and / or imaging devices, or may include only an imaging device (e.g., for diagnostic purposes).

[0091] In some embodiments, the treatment device includes one or more sensors configured to measure the insertion depth of the treatment device during the treatment process. The insertion depth can be communicated to the interactive treatment planning and mapping system so that the depth of the treatment device can be displayed in the imaging field 202, the fibroid map interface 204, or a combination of the two. In some instances, the treatment device is configured to measure the insertion angle of the treatment device during the treatment process. The insertion angle information can be communicated to the interactive treatment planning and mapping system for display in the imaging field 202, the fibroid map interface 204, or a combination of the two.

[0092] In some embodiments, the treatment device may include one or more sensors configured to determine the device position and / or orientation relative to other objects (such as, for example, a fibroid location, a user, one or more locations on a patient, combinations thereof, and the like). Information corresponding to the sensed position and / or orientation is transmitted to the interactive treatment planning and mapping system. The position and / or orientation information between the treatment device and the fibroid to be ablated may be captured by an external tracking system (e.g., as a non-limiting example, an optical tracking system). The tracking system may be configured to obtain at least one of the position, orientation, and motion information of the treatment device used. The information sensed by the tracking system may be transmitted to the interactive treatment planning and mapping system. The system may be configured to receive the information and display it in the imaging field 202, the fibroid map interface 204, or a combination of the two. The position and / or orientation information may be determined by any suitable method of measuring and determining the position and orientation of an object in three-dimensional space. For example, an optical tracking system and / or an inertial sensor (e.g., a gyroscope sensor and / or an accelerometer) may be configured to obtain one or more of the position, orientation, and motion information of the treatment device. In some examples, the therapeutic device may include visual indicia that provide placement and / or location indications to a user. For example, the therapeutic device may be annotated with a positioning indicator (e.g., a depth indicator) along at least a portion of the therapeutic device to orient a user interacting with the therapeutic device. The indicator may be active (e.g., a light emitting diode) and / or passive (e.g., an optically recognizable pattern).

[0093] In some implementations, the therapeutic device may include an alignment system that periodically transmits a signal that can be captured by one or more corresponding receivers. In some embodiments, the one or more receivers can directly sense the signal from the therapeutic device. The alignment system may include an electromagnetic radiation source and transmit a signal including electromagnetic radiation. For example, the source may be configured to transmit a signal that can travel through one or more portions of the patient's anatomy to be received by a corresponding receiver located outside the patient's cavity.

[0094] The positioning and / or orientation information transmitted to the interactive treatment planning and mapping system can be used in conjunction with the fibroid data so that the position of the treatment device in the imaging field 202 and / or the fibroid map interface 204 corresponds to the actual position of the treatment device relative to one or more fibroids. The ability to obtain the positioning and / or orientation data of the treatment device when the user performs a treatment or diagnostic procedure can help the user perform fibroid treatment at an optimal location. For example, during the treatment process, the interactive treatment planning and mapping system can instruct the user via the imaging field 202 and / or the fibroid map interface 204 to guide the treatment device to the appropriate depth, positioning and / or orientation for the treatment process. In some instances, the movement of the treatment device can be projected in real time on the imaging field 202 and / or the fibroid map interface 204 during the treatment process. For example, as the treatment device moves through the patient's cavity, the position of the distal tip of the treatment device can be identified on the imaging field 202 and / or the fibroid map interface 204. When the treatment device is located at the target location within the patient's cavity, the treatment device may be located at the target location in the imaging field 202 and / or the fibroid map interface 204. The user interface is updated with the treatment data.

[0095] exist Figure 1 At block 114, as shown, in response to the user's actions, the user interface 200 may be updated before and / or during the treatment process. In some embodiments, the system may update the user interface 200 after the treatment process begins. The updated user interface 200 may include data acquired from the treatment device (e.g., ultrasound device and ablation device). For example, as discussed above, the user interface 200 may display information about the treatment device, treatment parameters, the date and / or time of the treatment, and other treatment information described in more detail herein. In some embodiments, as described above, the user interface 200 may display information about the treatment device, treatment parameters, the date and / or time of the treatment, and other treatment information described in more detail herein. Figure 4-5 As shown, the fibroid map interface 204 may be updated to include treatment parameters 220. The displayed treatment parameters may include the angle of the ultrasound transducer relative to the longitudinal axis of the injection needle ("Angle"), the ablation diameter along the short axis ("Size"), the injection needle deployment depth ("Intro"), the electrode deployment length, and / or other treatment data.

[0096] The user interface 200 may also include a treatment data interface 222 detailing elapsed treatment time, remaining treatment time, ablation treatment volume, ablation treatment area, ablation time, ablation temperature, electrode and / or tissue impedance, RF power, RF temperature, and / or any other desired treatment data. In some embodiments, the treatment data interface 222 may include a power graph 224 showing the relationship between time and RF power. The treatment data interface 222 may include a temperature graph 226 showing the relationship between time and the mapped fibroid temperature.

[0097] In various embodiments, fibroid and / or treatment data may be received and processed by the system at any time and / or continuously. Figure 1 118, the system may determine whether the treatment process has terminated. In some embodiments, termination may be determined by the user clicking on the treatment report button 214 or completing treatment of all mapped fibroids. If the treatment process has not terminated, the system may continually update the user interface 200 as the treatment process continues, as indicated by arrow 120. In embodiments, treatment data may be updated even if the user is viewing data on the user interface 200. For example, the user may use the system to analyze substantially real-time treatment data through the treatment interface 222 and / or the fibroid map interface 204.

[0098] In various embodiments, the system may provide a color-coded representation. For example, the system may characterize the fibroid icon 216 into various categories, such as treatment status categories: untreated, treated, previously treated but recurring fibroid, or untreated with previously failed treatment attempts. Individual categories may result in changes to the visual representation of the fibroid icon 216. For example, Figure 4 As shown, the color-coded representation of the fibroid icon 217T can indicate a treated fibroid, while the fibroid icon 219U can indicate an untreated fibroid. The user can interact with the fibroid category before, during, and / or after the treatment process. In some embodiments, the user can manually change the fibroid icon 216 to modify the treatment status of the fibroid icon 216 from "untreated" to "treated" after the fibroid is treated. Optionally, the system can automatically modify the treatment status of the fibroid icon 216 based on the treatment data received from the treatment device. The change in treatment status can automatically change the visual representation of the fibroid icon 216 to appropriately indicate the updated fibroid treatment status. In some embodiments, the category of untreated fibroids can issue a warning or alarm to the user related to the fibroid. If the fibroid is treated a second time, for example because the first treatment cannot capture the entire fibroid or a portion of the fibroid to be treated, the fibroid icon 216 can change to a third color with a treatment amount indicator (e.g., "2"), combinations thereof, and the like.

[0099] IV. Sample Treatment Report

[0100] As discussed earlier, in Figure 1 At block 122, the system may automatically generate a treatment report 600, 700 after the treatment process is terminated, such as Figure 6-7 The user can interact with the treatment report button 214 to instruct the system to generate a treatment report 600. For example, Figure 4After the fibroid is treated at the time 217T, the user clicks the treatment report button 214 to generate a Figure 6 Report 600, and can be found at Figure 5 After all fibroids have been treated at the time, the user clicks the treatment report button 214 to generate a Figure 7 Report 700.

[0101] The treatment reports 600, 700 may detail treatment information obtained during the treatment process. For example, the treatment reports 600, 700 may include information related to fibroid location, estimated fibroid size, fibroid treatment status, number of fibroids, fibroid treatment sequence, ultrasound device information (e.g., ultrasound device serial number), ultrasound transducer angle, ablation device information (e.g., ablation device serial number), injection needle deployment depth, electrode deployment length, planned fibroid size, ablation data, ablation data, ablation treatment volume, ablation treatment area, ablation time, ablation temperature, electrode and / or tissue impedance, RF power, RF temperature, time-temperature curve, time-RF power curve, ablation safety zone distance, photos and / or screenshots of the imaging field, treatment process information, treatment time, treatment length, treatment date, patient data, attending physician and / or nurse, user and / or physician notes, and other fibroid and / or treatment information.

[0102] Figure 6 An example treatment report 600 is shown. In some embodiments, the treatment report 600 can include the fibroid map interface 204 and a separate fibroid report 602. For example, Figure 6 As shown, the treatment process may be limited to a single fibroid. In this example, the treatment report 600 may include only one fibroid report 602. The report may include information about all mapped fibroids, only the treated fibroids (e.g., Figure 6 The report may include warning signs associated with the fibroids (e.g., red text indicating that the treatment time is not commensurate with the estimated size). Figure 7 As shown, treatment report 700 may include multiple fibroid reports 702 .

[0103] In some embodiments, the treatment report 600, 700 and / or fibroid report 602, 702 may be exported to one or more databases. The system may export the report 600, 700 via a wired and / or wireless connection.

[0104] V. Exploration process

[0105] The interactive treatment mapping and planning system may include a preliminary exploration process. The system may enable a user to more effectively gather fibroid information during the exploration process, construct a fibroid map that provides a visual representation of the gathered fibroid information, and generate an exploration report.

[0106] Fig. 9 A flowchart depicting an illustrative operation of a preliminary exploration process is shown. In various embodiments, fewer blocks or additional blocks may be included in the process, or the process may be performed in a manner similar to that described in the example of FIG. Fig. 9 The various blocks are executed in a different order than shown. In an embodiment, Fig. 9 One or more blocks in can be Figure 8 The illustrated interactive treatment mapping and planning system 800 performs or is implemented in the interactive treatment mapping and planning system 800 .

[0107] At block 902, various fibroid data may be identified during a preliminary exploration procedure performed by a diagnostic test such as transcervical uterine ultrasound, laparoscopic ultrasound, or intrauterine ultrasound. At block 904, the system may receive fibroid data from an imaging device.

[0108] In some instances, at block 902, diagnostic device placement and / or position data may be identified during the preliminary exploration process. The interactive treatment mapping and planning system may utilize any structure, device, method, or feature described herein related to the treatment device. For example, the diagnostic device may include one or more sensors to measure the positioning and orientation of the diagnostic device in three-dimensional space. The diagnostic device may transmit its positioning and / or orientation information to the interactive treatment planning and mapping system. The system may incorporate the positioning and orientation information into a user interface for display to the user. The method may end after such automatic mapping.

[0109] At block 906, a display is generated (and / or may be used to generate and display) similar to the above referenced Figure 2-5 The user interface of the fibroid mapping interface of the previously described user interface and fibroid mapping interface. The fibroid mapping interface can be constructed completely automatically based on the received data, completely by the user or a combination thereof. For example, the mapping interface can be automatically filled based on the received data and then manipulated by the user. In various embodiments, the system creates a visual representation of the fibroid data on the generated user interface, including, for example, a description of the fibroid, the location of the fibroid, the type of fibroid (e.g., intramural, submucosal, subserosal, pedunculated submucosal, pedunculated subserosal), the estimated size of the fibroid, the state before the treatment of the fibroid, the number of fibroids, the order of fibroid treatment, and other fibroid information. In some embodiments, the system creates a visual representation of the diagnostic device data on the generated user interface, including, for example, positioning, orientation, motion, and / or other device information.

[0110] Figures 10A-10D An example of a diagnostic device 1002 and a fibroid map interface 1004 is shown. The fibroid map interface 1004 can utilize any of the structures, devices, methods, or features described herein with respect to the interactive treatment mapping and planning system. In some instances, the system can receive fibroid data from the diagnostic device 1002 to automatically populate the fibroid map interface 1004 with the fibroid information. Through the exploration process, the diagnostic device 1002 can transmit the fibroid information (e.g., fibroid location) to the system for input into the fibroid map interface 1004. For example, according to certain devices described herein, the transmission of the fibroid information can be based at least in part on sensor data (e.g., providing positioning and / or orientation information). After locating a first fibroid, the system can automatically populate the fibroid map interface 1004 with the fibroid information. For example, as Fig. 10A and Fig. 10B As shown, the diagnostic device 1002 can identify fibroid 1 and transmit fibroid information to allow the system to display fibroid icon 1 on the fibroid map interface 1004. In some embodiments, the diagnostic device 1002 can identify multiple fibroids and transmit multiple fibroid information to be displayed on the fibroid map interface 1004. Fig. 10C and Fig. 10D As shown, in some examples, the diagnostic device 1002 can identify a fibroid 2 and transmit fibroid information to allow the system to display a fibroid icon 2 on the fibroid map interface 1004. As described herein, the system can generate fibroid information by aggregating information from diagnostic devices.

[0111] At block 908, the system determines whether the exploration process has terminated. As shown by arrow 910, if the exploration process has not terminated, the operation can continue to identify additional fibroids. For example, referring to Figure 3 , the fibroid icon 217 may be generated on a first pass of blocks 902, 904, 906, 908, and then a second icon may be generated on a second pass of blocks 902, 904, 906, 908, etc. At each block 906, the fibroid icon from that pass and the previous pass may be updated. If the exploration process has terminated, the process proceeds to block 912.

[0112] At block 912, the system can automatically generate a survey report after the survey process is terminated. The report can detail the survey information obtained during the survey process. For example, the report can include information about the fibroid, the imaging device (e.g., an ultrasound transducer), imaging parameters, the date and / or time of the survey process, and other information. The survey report can include automatic and / or manual treatment plan recommendations (e.g., marking fibroid icons based on the recommended treatment order rather than the order in which the fibroids were diagnosed).

[0113] In various embodiments, the system may export a fibroid data file including the constructed fibroid map interface and / or exploration report. The exploration report may be readable to automatically populate the fibroid interface map 204.

[0114] VI. Implementation Mechanism

[0115] Figure 8 is to illustrate that various methods and functions described herein can be implemented (for example, reference Figure 1 and Fig. 9 Described methods of operation and reference Figure 2-5 The user interface 200 described and referenced Figure 6 and Figure 7 Block diagram of an example of an interactive treatment mapping and planning system 800 that depicts reports 600, 700).

[0116] As previously discussed, the interactive treatment mapping and planning system 800 may include an imaging device 814 (e.g., an ultrasound transducer or other imaging device), a display device 816, and an ablation device 818 configured to generate radiofrequency energy for treatment of abnormal tissue growth. The treatment system 800 may include any of the embodiments described and / or contemplated in U.S. Patent Nos. 8,088,072 (referred to herein as the '072 patent) and 8,992,427 (referred to herein as the '427 patent), which are incorporated herein by reference in their entireties. It will be understood that any of the embodiments described and / or contemplated in the '072 patent and the '427 patent may be modified for use with the various interactive treatment mapping and planning systems described herein. For example, in some embodiments, the '427 patent may include any of the embodiments described and / or contemplated in the '072 patent and the '427 patent. Figure 1 and Figure 2 Described in this application Figure 8 In some embodiments, the treatment system 800 may include the treatment probe 16, the imaging device 814 may include the imaging component 28, and the ablation device 818 may include the injection needle component 26, as described in the '427 patent. Figure 2 as shown in .

[0117] The interactive treatment mapping and planning system 800 may include a computing engine 806, a data source 804, an imaging device 814, a display device 816, and an ablation device 818. The system 800 may receive user (e.g., physician) input from one or more user computing devices 802. In embodiments, the computing device 802 may be any computing device capable of displaying a software application to a user and receiving input from a user. For example, the computing device 802 may include a smartphone, a tablet computer, a laptop, and / or other types of computing devices. The computing device 852 may be capable of communicating over a network, for example to request data from and / or provide data to components of the system 800. In some embodiments, the data source 804 may include a non-transitory computer-readable medium storage device for storing fibroid data 811a and / or treatment data 811b.

[0118] The computing engine 806 may perform various tasks to implement the operation of the interactive treatment mapping and planning system. The computing engine 806 may include a hardware processor 808, a memory 810 (which may store code modules executed by the processor 808), and a communication interface 812 for transferring information to and / or from other components of the system 800.

[0119] The computing engine 806 may include one or more software modules that are stored in the memory 810 and that when executed by the processor 808 may, for example, receive fibroid data 811a and / or treatment data 811b from the data source 804, process the received data, generate the user interface 200 and / or user interface data for display by the display device 816, process input from a user received from the computing device 802 or via the user interface (UI) 200 of the display device 816, and / or update the user interface 200. The processor 808 may be programmed to execute the reference Figure 1 and Fig. 9 Embodiments of the methods described.

[0120] The computing engine 806 may also communicate with a data source 804. The data source 804 may include an electronic storage device local to the computing engine 806. The data source 804 may be embodied in a hard drive, solid-state memory, and / or any other type of non-transitory computer-readable storage medium accessible remotely or locally to the computing engine 806. The fibroid data 811a and / or treatment data 811b may be distributed or partitioned across multiple storage devices and / or may be combined into a single database.

[0121] In various embodiments, the computation engine 806 or the data source 804 may be accessible to the user through a web-based viewer (e.g., a web browser) executed by the user computing device 802 or displayed as a display device 816. The display device 816 may be a computer monitor, a touch screen, an electronic (e.g., LCD or LED) display, etc. The user interface may be generated by the computation engine 806 and transmitted to a web browser of the user computing device 802 or the display device 816. Optionally, the data necessary to generate the user interface 200 may be provided by the computation engine 806 to the display device 816, where the user interface may be generated for display. The user may interact with the user interface 200 through the web browser or the display device 816. In embodiments, the user interface 200 of the interactive treatment mapping and planning system 800 may be accessible through a dedicated software application (rather than a web browser).

[0122] The interactive treatment mapping and planning system 800 and other methods and techniques described herein can be implemented by one or more special-purpose computing devices (e.g., processor 808 and memory 810). The special-purpose computing device can be hardwired to perform these techniques, or can include digital electronic devices, such as one or more application-specific integrated circuits (ASICs) or field programmable gate arrays (FPGAs) that are permanently programmed to perform these techniques, or can include one or more general-purpose hardware processors that are specifically programmed to perform these techniques according to program instructions in firmware, in executable code modules stored in memory 810, other storage devices, or a combination thereof. Such a special-purpose computing device can combine custom hard-wired logic, ASICs, or FPGAs with custom programming to implement these techniques. The special-purpose computing device can be a desktop computer system, a server computer system, a portable computer system, a handheld device, a networking device, or any other device or combination of devices that incorporates hard-wired and / or special program logic to implement the techniques described herein. The execution of the sequence of instructions contained in memory 806 causes the processor 804 to perform the process steps described herein.

[0123] VII. Examples

[0124] 1. A system comprising:

[0125] a non-transitory computer-readable storage medium configured to store program instructions; and

[0126] A processor programmed to execute program instructions causing the processor to:

[0127] aggregating a plurality of fibroid data records from one or more data sources;

[0128] extracting a fibroid data record item from a plurality of fibroid data records; and

[0129] Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising:

[0130] Interactive fibroid mapping, and

[0131] A visual representation of the fibroid data record item, the visual representation including a marker on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data item, the visual representation being configured to provide information related to the fibroid data record item.

[0132] 2. The system of example 1, wherein the processor is programmed to aggregate a plurality of fibroid data records from at least one of:

[0133] Input from the user;

[0134] User data source; or

[0135] Third-party data sources.

[0136] 3. The system of any of examples 1-2, wherein the fibroid data record includes a fibroid location.

[0137] 4. The system of any of examples 1-3, wherein the fibroid data record includes a fibroid size.

[0138] 5. The system of example 4, wherein the fibroid size comprises at least one of:

[0139] Small;

[0140] or

[0141] big.

[0142] 6. The system of any of examples 1-5, wherein the fibroid data record item includes a fibroid treatment status.

[0143] 7. The system of any of examples 1-6, wherein the fibroid data record item comprises a fibroid treatment sequence.

[0144] 8. The system of any of Examples 1-7, wherein the processor is further programmed to receive user input.

[0145] 9. The system of example 8, wherein the user input comprises at least one of the following:

[0146] User fibroid data entry; or

[0147] Treatment data record items.

[0148] 10. The system of example 9, wherein the processor is programmed to, in response to a user input:

[0149] updating one or more data sources with the user fibroid data record; and

[0150] The user interface data is updated so that the interactive user interface includes an indication of at least one of the user fibroid data record items.

[0151] 11. The system of any of Examples 8-10, wherein the user input includes export criteria, the export criteria including at least one of:

[0152] Export content;

[0153] export format; or

[0154] Export location.

[0155] 12. The system of example 11, wherein the processor is programmed to, in response to a user input:

[0156] extracting fibroid data export items associated with the export content from the fibroid data record;

[0157] Generate export documents including export formats and fibroid data export items;

[0158] storing the exported document at the export location; and

[0159] The user interface data is updated so that the interactive user interface includes an indication of the export request.

[0160] 13. The system of any one of Examples 1-12, wherein the interactive user interface further comprises a legend.

[0161] 14. The system of any of examples 1-13, wherein the visual representation comprises a fibroid icon.

[0162] 15. A system according to Example 14, wherein the visual representation is configured to indicate a warning to a user.

[0163] 16. The system of any of Examples 1-15, wherein the processor is programmed to:

[0164] Use information from imaging devices to identify fibroids;

[0165] receiving fibroid data from an imaging device; and

[0166] Generate a profile report.

[0167] 17. The system of any of Examples 1-16, wherein the processor is programmed to:

[0168] receiving fibroid data from one or more data sources;

[0169] Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising:

[0170] Interactive fibroid mapping, and

[0171] a visual representation of the fibroid data record item, the visual representation comprising a marker on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data item, the visual representation configured to provide information related to the fibroid data record item;

[0172] receiving treatment data from a treatment device; and

[0173] Updates the UI with treatment data.

[0174] 18. The system of Example 17, wherein the program is further programmed to generate a treatment report.

[0175] 19. A system comprising:

[0176] a non-transitory computer-readable storage medium configured to store program instructions; and

[0177] A processor programmed to execute program instructions causing the processor to:

[0178] Use information from imaging devices to identify fibroids;

[0179] receiving fibroid data from an imaging device; and

[0180] Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising:

[0181] Interactive fibroid mapping, and

[0182] A visual representation of the fibroid data record item, the visual representation including a marker on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data item, the visual representation being configured to provide information related to the fibroid data record item.

[0183] 20. The system according to Example 19 further includes an imaging device, wherein the imaging device includes an ultrasonic transducer.

[0184] 21. The system of any of the examples 19-20, wherein the program instructions further cause the processor to generate a probing report.

[0185] 22. A system comprising:

[0186] a non-transitory computer-readable storage medium configured to store program instructions; and

[0187] A processor programmed to execute program instructions causing the processor to:

[0188] receiving fibroid data from one or more data sources;

[0189] Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising:

[0190] Interactive fibroid mapping, and

[0191] a visual representation of the fibroid data record item, the visual representation comprising a marker on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data item, the visual representation configured to provide information related to the fibroid data record item;

[0192] receiving treatment data from a treatment device; and

[0193] Updates the UI with treatment data.

[0194] 23. The system of Example 22, wherein the program is further programmed to generate a treatment report.

[0195] 24. The system of any of Examples 22-23 further includes an imaging device, wherein the imaging device includes an ultrasound transducer.

[0196] 25. The system of any of Examples 22-24, further comprising an ablation device, wherein the ablation device comprises a radio frequency generator.

[0197] 26. A method of providing a system for treating a fibroid, the method comprising:

[0198] A system is provided that includes a processor programmed to execute program instructions such that the processor:

[0199] receiving fibroid data;

[0200] generating user interface data for rendering an interactive user interface on an electronic display;

[0201] receiving treatment data from a treatment device; and

[0202] updating the user interface with treatment data; and

[0203] The user is instructed to enter fibroid data.

[0204] 27. The method of example 26, further comprising instructing a user to determine a fibroid treatment sequence.

[0205] 28. The method of any of Examples 26-27, wherein the interactive user interface comprises:

[0206] Interactive fibroid mapping, and

[0207] A visual representation of the fibroid data record item, the visual representation including a marker on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data item, the visual representation being configured to provide information related to the fibroid data record item.

[0208] 29. A system comprising:

[0209] a non-transitory computer-readable storage medium configured to store program instructions;

[0210] an imaging device configured to transmit information; and

[0211] a processor programmed to execute program instructions to cause the processor;

[0212] receiving information from an imaging device; and

[0213] Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising:

[0214] fibroid mapping, and

[0215] A visual representation of the fibroid data record item, the visual representation including markings on the interactive fibroid map at respective fibroid locations associated with the fibroid data item, the visual representation configured to provide knowledge related to the fibroid data record item.

[0216] 30. The system of example 29, wherein the information includes at least one of a positioning of the imaging device, an orientation of the imaging device, an insertion depth, an insertion angle, a fibroid location, and a fibroid size.

[0217] 31. A system according to any of Examples 29-30, wherein the imaging device includes a sensor configured to determine at least one of a position and an orientation of the imaging device.

[0218] 32. A system according to example 31, wherein the information includes information representing at least one of a position and an orientation of the imaging device.

[0219] 33. The system of any of Examples 31-32, wherein the sensor comprises at least one of an optical tracking system, an inertial sensor, and a visual marker.

[0220] 34. A system according to any of Examples 31-33, wherein the imaging device further comprises an alignment marker configured to emit a signal including information representing at least one of a position and an orientation of the imaging device.

[0221] 35. The system of example 34, further comprising a receiver configured to receive a signal transmitted by the alignment marker.

[0222] 36. The system of any of Examples 34-35, wherein the alignment marker comprises an electromagnetic radiation source.

[0223] 37. The system of any of Examples 29-36 further comprises an ablation tool.

[0224] 38. A system according to example 37, wherein the ablation tool is coupled to an imaging device.

[0225] 39. The system of any of Examples 29-38, further comprising a tracking system configured to at least partially determine at least one of a position, orientation, and movement of the imaging device.

[0226] 40. The system of any of Examples 29-39, wherein the processor is configured to generate an interactive user interface using information received from the imaging device.

[0227] 41. The system according to any of examples 29-40, wherein the visual representation is configured to overlay the interactive fibroid map.

[0228] VIII. Additional Examples

[0229] Each process, method and algorithm described in the previous sections can be embodied in a code module stored in a memory and executed by one or more computer systems or computer processors including computer hardware, and fully or partially automated by the code module. The process and algorithm can be implemented in part or in whole in a dedicated circuit.

[0230] The various features and processes described above may be used independently of each other or in combination in various ways. All possible combinations and sub-combinations are expected to fall within the scope of the present disclosure. In addition, in some implementations, certain method or process blocks may be omitted. The methods and processes described herein are not limited to any particular order, and the blocks or states associated therewith may be executed in other suitable orders. For example, the blocks or states described may be executed in an order different from the order specifically disclosed, or multiple blocks or states may be combined into a single block or state. Example blocks or states may be executed continuously, in parallel, or in some other manner. Blocks or states may be added to or removed from the disclosed example embodiments. The example systems and components described herein may be configured differently from those described. For example, elements may be added to, removed from, or rearranged in comparison with the disclosed example embodiments.

[0231] Conditional language (such as, in particular, "can," "may," "might," or "perhaps," unless specifically stated otherwise or otherwise understood in the context as used) is generally intended to convey that certain embodiments include and other embodiments do not include certain features, elements, and / or steps. Thus, such conditional language is generally not intended to imply that features, elements, and / or states are in any way required for one or more embodiments, or that one or more embodiments must include logic for determining, with or without user input or prompting, whether such features, elements, and / or states are included or to be performed in any particular embodiment.

[0232] The term "comprising" as used herein should be given an inclusive rather than exclusive interpretation. For example, a general-purpose computer including one or more processors should not be interpreted as excluding other computer components, and may include such components as non-transitory memory, input / output devices and / or network interfaces together with other components. In addition, the term "or" is used in its inclusive sense (rather than in its exclusive sense) so that when used for a list of, for example, connected elements, the term "or" means one, some or all of the elements in the list. In addition, the articles "a", "an" and "the" as used in the present application and the appended claims should be interpreted as meaning "one or more" or "at least one", unless otherwise specified.

[0233] As used herein, the phrase "at least one" of a list of items refers to any combination of those items, including single members. As an example, "at least one of A, B, or C" is intended to cover: A, B, C, A and B, A and C, B and C, and A, B and C. Unless specifically provided otherwise, linking language (e.g., the phrase "at least one of X, Y, and Z") is otherwise understood with the context as commonly used to convey that an item, term, etc. can be at least one of X, Y, Z. Thus, such linking language is generally not intended to imply that certain embodiments require that at least one of X, at least one of Y, and at least one of Z each be present.

[0234] The processes, methods and systems may be implemented in a network (or distributed) computing environment. Network environments include enterprise-wide computer networks, intranets, local area networks (LANs), wide area networks (WANs), personal area networks (PANs), cloud computing networks, crowd-sourced computing networks, the Internet and the World Wide Web. The network may be a wired or wireless network or any other type of communication network.

[0235] Any process description, element or block in the flowchart described herein and / or depicted in the accompanying drawings should be understood to potentially represent a module, segment or portion of a code, which includes one or more executable instructions for implementing a specific logical function or step in the process. As understood by those skilled in the art, optional implementations are included within the scope of the embodiments described herein, wherein elements or functions may be deleted, executed in a different order (including substantially simultaneously or in reverse order) from the order shown or discussed, depending on the functions involved.

[0236] Code modules or any type of data may be stored on any type of non-transitory computer-readable medium (e.g., physical computer storage devices, including hard drives, solid-state memory, random access memory (RAM), read-only memory (ROM), optical disks, volatile or non-volatile storage devices, combinations thereof, and / or the like). Methods and modules (or data) may also be transmitted as generated data signals (e.g., as part of a carrier wave or other analog or digital propagation signal) on various computer-readable transmission media (including wireless-based and wire / cable-based media) and may take various forms (e.g., as part of a single or multiplexed analog signal, or as multiple discrete digital packets or frames). The results of the disclosed processes or process steps may be stored persistently or otherwise in any type of non-transitory tangible computer storage device, or may be communicated via a computer-readable transmission medium.

[0237] The ranges disclosed herein also include any and all overlaps, subranges, and combinations thereof. Language such as "up to," "at least," "greater than," "less than," "between," and the like includes the listed numbers. Numbers preceded by terms such as "about" or "approximately" include the listed numbers and should be interpreted based on the circumstances (e.g., as accurately as reasonably possible under the circumstances, e.g., ±5%, ±10%, ±15%, etc.). For example, "about 1" includes "1." Phrases preceded by terms such as "substantially," "substantially," and the like include the listed phrases and should be interpreted based on the circumstances (e.g., as accurately as reasonably possible under the circumstances). For example, "substantially spherical" includes "spherical." Unless otherwise specified, all measurements are under standard conditions, including temperature and pressure.

[0238] It should be emphasized that many changes and modifications can be made to the above-described embodiments, and the elements of these embodiments should be understood to be among other acceptable examples. All such modifications and changes are specified to be included in the scope of the present disclosure. The foregoing description details certain embodiments of the present invention. However, it will be appreciated that no matter how detailed the foregoing appears in the text, the present invention can be practiced in a variety of ways. As stated above, it should be noted that when describing certain features or aspects of the present invention, the use of specific terms should not be understood to imply that the term is redefined herein to be limited to including any specific characteristics of the features or aspects of the present invention associated with the term. The scope of the present invention should be interpreted in accordance with the appended claims and any equivalents thereof.

Claims

1. A system comprising: a non-transitory computer-readable storage medium configured to store program instructions; as well as a processor programmed to execute the program instructions so that the processor: aggregating a plurality of fibroid data records from one or more data sources; extracting a fibroid data record item from the plurality of fibroid data records; as well as Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising: Interactive fibroid mapping, and a visual representation of a fibroid data record item, the visual representation comprising a marker on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data record item, the visual representation being configured to provide information related to the fibroid data record item, wherein the system is configured to characterize a fibroid icon as various treatment status categories resulting in a change in a visual representation of the fibroid icon to modify the treatment status of the fibroid icon based on treatment data received from a treatment device, and to change the visual representation of the fibroid icon to indicate the updated fibroid treatment status.

2. The system according to claim 1, wherein: The processor is further programmed to automatically populate the interactive fibroid map with the visual representation of the fibroid data record.

3. The system according to claim 1, wherein: The corresponding fibroid location of the marker includes a graphical representation of the fibroid location in the patient's uterus.

4. The system according to claim 1, wherein: The processor is programmed to permit a user to manually populate the interactive fibroid map with the visual representation of the fibroid data record.

5. The system according to any one of claims 1 to 4, wherein: The processor is programmed to aggregate a plurality of fibroid data records from at least one of: Input from the user; User data source; or Third-party data sources.

6. The system according to any one of claims 1 to 4, wherein: The fibroid data record includes a fibroid location.

7. The system according to any one of claims 1 to 4, wherein: The fibroid data record includes a fibroid size.

8. The system according to claim 7, wherein: The fibroid size includes one of the following: Small; or big.

9. The system according to any one of claims 1 to 4, wherein: The fibroid data record includes a fibroid treatment status.

10. The system according to any one of claims 1 to 4, wherein: The fibroid data record includes a fibroid treatment sequence.

11. The system according to any one of claims 1 to 4, wherein: The fibroid data record includes a fibroid type.

12. The system according to claim 11, wherein: The fibroid type includes one of intramural, submucosal, subserosal, pedunculated submucosal, and pedunculated subserosal.

13. The system according to any one of claims 1 to 4, wherein: The fibroid data record includes the number of fibroids.

14. The system according to any one of claims 1 to 4, wherein: The processor is also programmed to receive user input.

15. The system of claim 14, wherein: The user input includes at least one of the following: User fibroid data entry; or Treatment data record items.

16. The system of claim 15, wherein: The processor is programmed to, in response to the user input: updating the one or more data sources with the user fibroid data record; and The user interface data is updated so that the interactive user interface includes an indication of at least one of the user fibroid data record items.

17. The system of claim 14, wherein: The user input includes export criteria, the export criteria including at least one of the following: Export content; export format; or Export location.

18. The system of claim 17, wherein: The processor is programmed to, in response to the user input: extracting fibroid data export items related to the export content from the plurality of fibroid data records; generating an export document including the export format and the fibroid data export items; storing the exported document at the export location; as well as The user interface data is updated so that the interactive user interface includes an indication of an export request.

19. The system according to any one of claims 1 to 4, wherein: The interactive user interface also includes a legend.

20. The system according to any one of claims 1 to 4, wherein: The visual representation includes a fibroid icon.

21. The system of claim 20, wherein: The visual representation is configured to indicate a warning to a user.

22. The system according to any one of claims 1 to 4, wherein: The processor is programmed to: Use information from imaging devices to identify fibroids; receiving fibroid data from the imaging device; and Generate a profile report.

23. The system according to any one of claims 1 to 4, wherein: The processor is programmed to: receiving fibroid data from one or more data sources; receiving treatment data from a treatment device; and The interactive user interface is updated with treatment data.

24. The system of claim 23, wherein: The processor is also programmed to generate a treatment report.

25. A system comprising: a non-transitory computer-readable storage medium configured to store program instructions; as well as a processor programmed to execute the program instructions so that the processor: receiving fibroid data from one or more data sources; Generating user interface data for rendering an interactive user interface on an electronic display, the interactive user interface comprising: Interactive fibroid mapping, and a visual representation of a fibroid data record item, the visual representation comprising a marking on the interactive fibroid map at a corresponding fibroid location associated with the fibroid data record item, the visual representation being configured to provide information related to the fibroid data record item; receiving treatment data from a treatment device; and updating the interactive user interface with treatment data, wherein the system is configured to characterize a fibroid icon as various treatment status categories resulting in a change in a visual representation of the fibroid icon to modify the treatment status of the fibroid icon based on treatment data received from the treatment device, and to change the visual representation of the fibroid icon to indicate the updated fibroid treatment status.

26. The system of claim 25, wherein: The processor is programmed to execute the program instructions to cause the processor to receive therapy data from a user.

27. The system of claim 25, wherein: The processor is programmed to execute the program instructions so that the processor updates the user interface with treatment data in substantially real time.

28. The system of claim 25, wherein: The treatment data includes at least one of a fibroid treatment sequence, treatment time, or ablation device information.

29. The system of claim 25, further comprising an imaging device.

30. The system of claim 29, wherein: The imaging device includes an ultrasound transducer.

31. The system of claim 30, wherein: The treatment data includes at least one of an ultrasound transducer angle or an ultrasound transducer position.

32. The system of claim 25, wherein: The therapeutic device comprises an ablation device.

33. The system of claim 32, wherein: The ablation device includes a radio frequency generator.

34. The system of claim 32, wherein: The treatment data includes at least one of the following: injection needle deployment depth, electrode deployment length, ablation data, ablation treatment volume, ablation treatment area, ablation time, ablation temperature, tissue impedance, RF power, RF temperature, time-temperature curve, or time-RF power curve.

35. The system according to any one of claims 25 to 34, wherein: The processor is also programmed to execute the program instructions to cause the processor to generate a treatment report.

36. The system of claim 35, wherein: The treatment report includes information about treatment parameters.

37. The system of claim 35, wherein: The treatment report includes information regarding at least one of: fibroid location, estimated fibroid size, fibroid treatment status, number of fibroids, or fibroid treatment sequence.

38. The system of claim 35, wherein: The treatment report is generated in response to user interaction with a treatment report button.

39. The system of claim 35, wherein: The treatment report includes at least one of the interactive fibroid map or a separate fibroid report.

40. The system of claim 35, wherein: The treatment report includes fibroid warning signs regarding fibroids.

41. The system of any one of claims 25-34, wherein: The processor is also programmed to execute the program instructions to cause the processor to generate a plurality of fibroid reports.

Images